Syn-Tech Chem. & Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
May 04, 2021 at 02:32 pm
Share
SYN-TECH Chem. & Pharm. Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 235.583 million compared to TWD 235.327 million a year ago. Operating income was TWD 63.628 million compared to TWD 51.869 million a year ago. Net income was TWD 51.972 million compared to TWD 46.890 million a year ago. Basic earnings per share was TWD 1.73 compared to TWD 1.56 a year ago.
SYN-TECH Chem. & Pharm. Co., Ltd. is a Taiwan-based company principally engaged in the production, processing and distribution of active pharmaceutical ingredients (APIs). The Companyâs main products consist of muscle relaxants, local anesthetics, cardiovascular agents, antipyretics, analgesics and anti-inflammatory drugs, antimicrobials, spirit stabilizers, intermediates and others. It is also engaged in the pharmaceutical agency business. The Company distributes its products within Taiwan market and to overseas markets, including Asia, Europe, the Americas and Africa.